SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225839
Filing Date
2012-05-10
Accepted
2012-05-10 16:59:30
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d327851d10q.htm 10-Q 364477
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY d327851dex104.htm EX-10.4 10626
3 SECTION 302 CEO CERTIFICATION d327851dex311.htm EX-31.1 5867
4 SECTION 302 CFO CERTIFICATION d327851dex312.htm EX-31.2 5877
5 SECTION 906 CEO CERTIFICATION d327851dex321.htm EX-32.1 3832
6 SECTION 906 CFO CERTIFICATION d327851dex322.htm EX-32.2 3792
  Complete submission text file 0001193125-12-225839.txt   1710737

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ccxi-20120331.xml EX-101.INS 203796
8 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20120331.xsd EX-101.SCH 8899
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20120331_cal.xml EX-101.CAL 30078
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20120331_def.xml EX-101.DEF 26849
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20120331_lab.xml EX-101.LAB 105358
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20120331_pre.xml EX-101.PRE 67813
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 12831089
SIC: 2834 Pharmaceutical Preparations